Key Points
Wegovy to treat obesity in 2021 or 2022 were still taking it a year later, more than three times the rate of adherence with older medicines, according to an analysis of medical records and insurance claims data...
Only 13% of patients who started taking Contrave from Orexigen Therapeutics and 10% of those who started on Qsymia from Vivus between 2015 and 2022 were still filling their prescriptions a year later, researchers reported on Wednesday in the journal Obesity...
A July data analysis by pharmacy benefits manager Prime Therapeutics of 4,255 people with commercial health plans who had been prescribed GLP-1 drugs in 2021 found that only about a third were still taking it a year later...
Wegovy carries a list price of $1,349 per-package, while Eli Lilly's newer rival drug Zepbound is listed at $1,059.87 a month, although most patients will pay far less, especially if they have commercial insurance that covers the treatments...
"The high costs of novel anti-obesity medications and non-persistence with (these drugs) are increasingly becoming a concern and could inform decisions regarding coverage by third-party payers," said study leader Dr..
You might be interested in
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
05, Dec, 23Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, a Reuters analysis found. It concentrated that money on an elite group of obesity specialists who advocate giving its powerful and expensive drugs to tens of millions of Americans.
The Obesity Drug Revolution Just Got Real
08, Aug, 23Wegovy reduces risk of heart attack, stroke in study, paving way for greater insurance coverage
Weight-loss drugs: What and for whom are they good for?
02, Jan, 24Can weight-loss drugs treat heart and kidney diseases to conditions such as Parkinson's and alcohol addiction? What and for whom are these drugs good for? | Health
Belgium seizes fake weight-loss drugs containing insulin
30, Oct, 23Belgium’s drug regulator said it had seized counterfeit versions of semaglutide, the active ingredient in Novo Nordisk's (NOVOb.CO) popular obesity drug Wegovy, in which the injector pens contained insulin.
Mental health: Here's how obesity impacts social life, psychological illness
11, Mar, 23Obesity and mental health issues often coexist and are together referred to as the twin epidemic. It is seen that psychological issues may lead to obesity and some-times obesity may lead to issues like depression. Expert reveals how | Health
Exclusive: WHO to consider adding obesity drugs to 'essential' medicines list
02, Apr, 23Drugs that combat obesity are under consideration for the first time for the World Health Organization's "essential medicines list," used to guide government purchasing decisions in low- and middle-income countries, the U.N. agency told Reuters.
Weight loss from Eli Lilly’s Zepbound reversed slowly after treatment stopped
11, Dec, 23People who stopped taking Eli Lilly & Co.’s Zepbound after about eight months regained half the weight they’d lost a year later, as per a study. | Health
Why People Stop Using Drugs Like Ozempic
07, Jul, 23Drugs like semaglutide—better known as Ozempic or Wegovy—could be lifelong treatments for obesity, but what little data scientists have suggests that people don't stick with them for long.
Economists warn of costs if Medicare covers new obesity drugs
18, Mar, 23The cost of expanding U.S. Medicare prescription drug coverage to pay for expensive, new obesity medications could be catastrophic, health economists warned in a report published on Saturday.